一分钟看懂
这是一项关于宫颈癌的不适用研究，登记的药物或干预包括Moderately fractionated radiotherapy using online adaptive radiotherapy technology；Conventionally fractionated radiotherapy using image-guid，当前状态为招募中。登记地点显示中国北京有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Moderately fractionated radiotherapy using online adaptive radiotherapy technology；Conventionally fractionated radiotherapy using image-guided intensity-modulated radiotherapy technol · 不适用
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Peking Union Medical College Hospital · 北京
公开的入选条件
- 1. Participants must be fully voluntary and have decision-making capacity, providing written informed consent within 30 days prior to enrollment.
- 2. Age ≥18 years and ≤75 years.
- 3. ECOG performance status of 0-1, and expected to tolerate lying supine for half an hour.
- 4. Have undergone radical surgery for cervical cancer (procedure: radical hysterectomy + pelvic lymphadenectomy ± para-aortic lymphadenectomy) or surgery for endometrial cancer (procedure: total hysterectomy + bilateral salpingo-oophorectomy ± pelvic and/or pa
- 5. For participants with cervical cancer, the following criteria must be met:
- (1)Pathologically diagnosed with cervical squamous cell carcinoma or adenocarcinoma.
- (2)Must have at least one of the following high-risk factors; or have other risk factors requiring postoperative radiotherapy: High-risk factors: Pelvic lymph node metastasis, or positive surgical margin, or parametrial invasion.
- Other risk factors: Middle or deep one-third stromal invasion, regardless of tumor size and LVSI status; Tumor size ≥4cm, regardless of depth of stromal invasion and LVSI status; Adenocarcinoma: Tumor size ≥2cm, or positive LVSI, regardless of depth of stromal
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07584161；登记信息更新于 2026-09-16。